Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs FMmeds

CoraDoc
Graded #49

Higher grade

vs+13.299999999999997
FMmeds
Graded #261

Lower grade

The verdict

CoraDoc takes it — 76.5/100 to 63.2/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoraDoc +49
95
46
Dose & formulationEven
72
72
Clinical oversightCoraDoc +9
79
70
Labs & monitoringEven
53
53
FulfillmentFMmeds +21
76
97
Contract termsCoraDoc +22
69
47
CoraDoc · left barFMmeds · right bar

The numbers

MetricCoraDocFMmeds
WeighScore76.5/10063.2/100
GradeCC
Scorecard rank#49#261
Semaglutide$99/mo (all doses, compounded)$225/mo (all doses, compounded)
Tirzepatide$165/mo (all doses, compounded)$265/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoraDoc

Graded #49 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

Where it loses points

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site
FMmeds

Graded #261 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard